InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the complete record of transactions filed by Royston Ivor, 董事长兼首席执行官. Officer active across 2 companies, notably Viracta Therapeutics, Inc.. Aggregated, 15 reports have been logged. Split: 1 buy · 0 sell. Total volume traded: €39k. History available since 15 November 2021. The latest transaction was disclosed on 25 November 2024 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
15 条申报中的 15 条
ROYSTON IVOR is Président-Directeur Général and a director of Viracta Therapeutics, Inc. The 15 filings on record cover the period from 2021-11-15 to 2024-11-27, and the sampled recent filings show buys of EUR 38876 and no sales, with option exercise as the modal transaction nature.